SEC Insider Transactions from Hoitt Jason.

Last updated: 2026-03-19 23:02 UTC | Total transactions: 9

Hoitt Jason has filed 9 insider transactions across 1 company since February 2026.

Most recent transaction: a sale of 139 shares of Stoke Therapeutics, Inc. ($STOK) on March 18, 2026.

Activity breakdown: 0 open-market purchases and 5 sales.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
March 18, 2026 Stoke Therapeutics, Inc. $STOK Hoitt Jason Chief Patient Officer S Common Stock 139 $31.79 10,306.0000 60,397,681 1.33% 0.00%
March 18, 2026 Stoke Therapeutics, Inc. $STOK Hoitt Jason Chief Patient Officer S Common Stock 30 $32.85 10,276.0000 60,397,681 0.29% 0.00%
March 17, 2026 Stoke Therapeutics, Inc. $STOK Hoitt Jason Chief Patient Officer S Common Stock 1033 $32.74 12,955.0000 60,397,681 7.38% 0.00%
March 17, 2026 Stoke Therapeutics, Inc. $STOK Hoitt Jason Chief Patient Officer S Common Stock 748 $33.38 12,207.0000 60,397,681 5.77% 0.00%
March 18, 2026 Stoke Therapeutics, Inc. $STOK Hoitt Jason Chief Patient Officer S Common Stock 1762 $31.28 10,445.0000 60,397,681 14.43% 0.00%
March 15, 2026 Stoke Therapeutics, Inc. $STOK Hoitt Jason Chief Patient Officer M Common Stock 10000 $0.00 13,988.0000 60,397,681 250.75% 0.02%
March 15, 2026 Stoke Therapeutics, Inc. $STOK Hoitt Jason Chief Patient Officer M Restricted Stock Units 10000 $0.00 30,000.0000 60,397,681 25.00% 0.02%
Feb. 17, 2026 Stoke Therapeutics, Inc. $STOK Hoitt Jason Chief Patient Officer A Employee Stock Option (Right to Buy) 72000 $0.00 72,000.0000 60,397,681 9999.99% 0.12%
Feb. 17, 2026 Stoke Therapeutics, Inc. $STOK Hoitt Jason Chief Patient Officer A Restricted Stock Units 48000 $0.00 48,000.0000 60,397,681 9999.99% 0.08%